Literature DB >> 17215365

Biomimetic amplification of nanoparticle homing to tumors.

Dmitri Simberg1, Tasmia Duza, Ji Ho Park, Markus Essler, Jan Pilch, Lianglin Zhang, Austin M Derfus, Meng Yang, Robert M Hoffman, Sangeeta Bhatia, Michael J Sailor, Erkki Ruoslahti.   

Abstract

Nanoparticle-based diagnostics and therapeutics hold great promise because multiple functions can be built into the particles. One such function is an ability to home to specific sites in the body. We describe here biomimetic particles that not only home to tumors, but also amplify their own homing. The system is based on a peptide that recognizes clotted plasma proteins and selectively homes to tumors, where it binds to vessel walls and tumor stroma. Iron oxide nanoparticles and liposomes coated with this tumor-homing peptide accumulate in tumor vessels, where they induce additional local clotting, thereby producing new binding sites for more particles. The system mimics platelets, which also circulate freely but accumulate at a diseased site and amplify their own accumulation at that site. The self-amplifying homing is a novel function for nanoparticles. The clotting-based amplification greatly enhances tumor imaging, and the addition of a drug carrier function to the particles is envisioned.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215365      PMCID: PMC1783417          DOI: 10.1073/pnas.0610298104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes.

Authors:  Maud B Gorbet; Michael V Sefton
Journal:  Biomaterials       Date:  2004-11       Impact factor: 12.479

2.  Superparamagnetic iron oxide: pharmacokinetics and toxicity.

Authors:  R Weissleder; D D Stark; B L Engelstad; B R Bacon; C C Compton; D L White; P Jacobs; J Lewis
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

3.  Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.

Authors:  T T Suh; K Holmbäck; N J Jensen; C C Daugherty; K Small; D I Simon; S Potter; J L Degen
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

4.  Regulation of extravascular coagulation by microvascular permeability.

Authors:  H F Dvorak; D R Senger; A M Dvorak; V S Harvey; J McDonagh
Journal:  Science       Date:  1985-03-01       Impact factor: 47.728

5.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

6.  Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy.

Authors:  Phil Oh; Yan Li; Jingyi Yu; Eberhard Durr; Karolina M Krasinska; Lucy A Carver; Jacqueline E Testa; Jan E Schnitzer
Journal:  Nature       Date:  2004-06-10       Impact factor: 49.962

7.  The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes.

Authors:  R L Souhami; H M Patel; B E Ryman
Journal:  Biochim Biophys Acta       Date:  1981-05-18

Review 8.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

Authors:  N Van Rooijen; A Sanders
Journal:  J Immunol Methods       Date:  1994-09-14       Impact factor: 2.303

9.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.

Authors:  C W Jung; P Jacobs
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

10.  Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.

Authors:  C W Jung
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

View more
  144 in total

1.  In vivo assembly of nanoparticle components to improve targeted cancer imaging.

Authors:  Steven D Perrault; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

Review 3.  Inorganic nanoparticle-based contrast agents for molecular imaging.

Authors:  Eun Chul Cho; Charles Glaus; Jingyi Chen; Michael J Welch; Younan Xia
Journal:  Trends Mol Med       Date:  2010-11-10       Impact factor: 11.951

4.  Nanotechnology: Platelet mimicry.

Authors:  Omid C Farokhzad
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

Review 5.  Smart nanosystems: Bio-inspired technologies that interact with the host environment.

Authors:  Ester J Kwon; Justin H Lo; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

Review 6.  Targeted Nanotherapies for the Treatment of Surgical Diseases.

Authors:  Courtney E Morgan; Molly A Wasserman; Melina R Kibbe
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

7.  Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.

Authors:  Lily Yang; Zehong Cao; Hari Krishna Sajja; Hui Mao; Liya Wang; Huaying Geng; Hengyi Xu; Tieshan Jiang; William C Wood; Shuming Nie; Y Andrew Wang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

8.  Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  J Control Release       Date:  2010-03-23       Impact factor: 9.776

Review 9.  Targeted hyperthermia using metal nanoparticles.

Authors:  Paul Cherukuri; Evan S Glazer; Steven A Curley
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 10.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.